Immunoblotting is an experimental method commonly used in molecular biology, biochemistry and immunogenetics. The basic principle is to stain cells or biological tissue samples processed by gel electrophoresis with specific antibodies. Obtain information on the expression of specific proteins in the cells or tissues analyzed by analyzing the location and depth of staining. The Automated immunoblotting Processor is a quantitative analysis system based on immunoblot analysis.
This report contains market size and forecasts of Automated Immunoblotting Processors in global, including the following market information:
Global Automated Immunoblotting Processors Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Automated Immunoblotting Processors Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Automated Immunoblotting Processors companies in 2021 (%)
The global Automated Immunoblotting Processors market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Dry Blotting Systems Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Automated Immunoblotting Processors include Bio-Rad Laboratories, Thermo Fisher Scientific, GE Healthcare, Bio-Techne, Merck, PerkinElmer, Endress+Hauser, Gen Script Biotech and Expedeon, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Automated Immunoblotting Processors manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Automated Immunoblotting Processors Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Automated Immunoblotting Processors Market Segment Percentages, by Type, 2021 (%)
Dry Blotting Systems
Semi-Dry Blotting Systems
Others
Global Automated Immunoblotting Processors Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Automated Immunoblotting Processors Market Segment Percentages, by Application, 2021 (%)
Diagnostic Laboratories
Pharmaceutical and Biotechnology Companies
Research & Academic Institution
Others
Global Automated Immunoblotting Processors Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Automated Immunoblotting Processors Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Automated Immunoblotting Processors revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Automated Immunoblotting Processors revenues share in global market, 2021 (%)
Key companies Automated Immunoblotting Processors sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Automated Immunoblotting Processors sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bio-Rad Laboratories
Thermo Fisher Scientific
GE Healthcare
Bio-Techne
Merck
PerkinElmer
Endress+Hauser
Gen Script Biotech
Expedeon
ATTO Corporation
Tecan
Life Technologies
ProteinSimple
Euroimmun
Precision Biosystems
Cytoskeleton
MedSupply Partners
LI-COR Biosciences
Cytiva
Molecular Devices